Biotech’s Rare-Disease Darling Returns as FDA Hard-Liners Depart
Investor confidence surges in rare-disease biotech as the FDA’s strict regulatory stance softens, paving the way for renewed investment and accelerated drug development.
Investor confidence surges in rare-disease biotech as the FDA’s strict regulatory stance softens, paving the way for renewed investment and accelerated drug development.
Nathan Fielder’s A24 documentary about Elizabeth Holmes, ‘You Can See Everything,’ unveils a tense trailer after receiving perfect reviews at Telluride.
Denmark’s Prime Minister Mette Frederiksen identifies a growing internal threat from failed migrant integration, echoing concerns about radical Islam and challenging European norms.
DNC Chair Ken Martin calls Hasan Piker’s remarks ‘disgusting and deplorable,’ distancing the party from the far-left streamer.
Dodgers owner Mark Walter’s business dealings are under scrutiny as prosecutors investigate four companies allegedly used to funnel loan proceeds.
A Nevada casino, saved from closure, is now luring tourists away from Las Vegas with lower prices and no resort fees.
An armed officer’s presence thwarted a planned synagogue massacre on Yom Kippur, sparking urgent demands for legal authorization for armed security at Canadian Jewish institutions amidst rising antisemitism.
Ford slashes 2027 prices on Maverick and Bronco Sport, but restricts engine options and cuts features on some trims.
U.S. 10-year yields break 5% and German Bunds hit 15-year highs as energy market volatility fuels inflation fears and prompts a global yield surge.
NYPD Detective Jose Mercedes, stabbed seven times during an off-duty robbery, leaves the hospital on foot to cheers from fellow officers.